ChromaDex Corporation NASDAQ:CDXC

Founder-led company

ChromaDex stock price today

$7.886
+2.36
+42.86%
Financial Health
0
1
2
3
4
5
6
7
8
9

ChromaDex stock price monthly change

+111.49%
month

ChromaDex stock price quarterly change

+111.49%
quarter

ChromaDex stock price yearly change

+280.69%
year

ChromaDex key metrics

Market Cap
415.37M
Enterprise value
83.52M
P/E
-6.22
EV/Sales
1.15
EV/EBITDA
-5.38
Price/Sales
1.38
Price/Book
3.47
PEG ratio
-0.15
EPS
-0.04
Revenue
83.16M
EBITDA
-1.60M
Income
-3.52M
Revenue Q/Q
-1.78%
Revenue Y/Y
7.52%
Profit margin
-22.96%
Oper. margin
-25.85%
Gross margin
59.4%
EBIT margin
-25.85%
EBITDA margin
-1.93%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ChromaDex stock price history

ChromaDex stock forecast

ChromaDex financial statements

ChromaDex Corporation (NASDAQ:CDXC): Profit margin
Jun 2023 20.32M -2.19M -10.78%
Sep 2023 19.49M -959K -4.92%
Dec 2023 21.19M 114K 0.54%
Mar 2024 22.15M -492K -2.22%
ChromaDex Corporation (NASDAQ:CDXC): Analyst Estimates
Mar 2024 22.15M -492K -2.22%
Sep 2025 28.8M 1.12M 3.91%
Oct 2025 29.3M 1.50M 5.14%
Dec 2025 31.03M 2.25M 7.27%
  • Analysts Price target

  • Financials & Ratios estimates

ChromaDex Corporation (NASDAQ:CDXC): Debt to assets
Jun 2023 53171000 26.02M 48.94%
Sep 2023 53483000 26.17M 48.94%
Dec 2023 54964000 26.50M 48.23%
Mar 2024 54079000 25.12M 46.47%
ChromaDex Corporation (NASDAQ:CDXC): Cash Flow
Jun 2023 3.28M -5K -10K
Sep 2023 396K -26K -3K
Dec 2023 574K -21K -1K
Mar 2024 284K -41K -3K

ChromaDex alternative data

ChromaDex Corporation (NASDAQ:CDXC): Employee count
Aug 2023 113
Sep 2023 113
Oct 2023 113
Nov 2023 113
Dec 2023 113
Jan 2024 113
Feb 2024 113
Mar 2024 106
Apr 2024 106
May 2024 106
Jun 2024 106
Jul 2024 106

ChromaDex other data

30.15% +0.54%
of CDXC is owned by hedge funds
20.25M +49.92K
shares is hold by hedge funds

ChromaDex Corporation (NASDAQ:CDXC): Insider trades (number of shares)
Period Buy Sel
Aug 2024 11408715 11431715
Nov 2024 2907 0
Dec 2024 0 37161
Transaction Date Insider Security Shares Price per share Total value Source
Option
JAKSCH FRANK L JR director Common Stock 50,001 $3.66 $183,004
Sale
JAKSCH FRANK L JR director Common Stock 37,161 $6.19 $229,952
Option
JAKSCH FRANK L JR director Employee Stock Options (right to buy) 50,001 $3.66 $183,004
Purchase
PAMIR OZAN officer: Chief Financial Officer
Common Stock 2,907 $7.36 $21,396
Option
PATRICK KRISTIN director
Common Stock 20,000 $1.67 $33,400
Option
PATRICK KRISTIN director
Stock Option (right to buy) 3,000 $1.64 $4,920
Option
PATRICK KRISTIN director
Common Stock 3,000 $1.64 $4,920
Sale
PATRICK KRISTIN director
Common Stock 23,000 $3.57 $82,110
Option
PATRICK KRISTIN director
Stock Option (right to buy) 20,000 $1.67 $33,400
Sale
LI KA SHING 10 percent owner
Common Stock 11,408,715 $32,058,489.15 $365,746,166,042,942
Insider Compensation
Mr. Robert N. Fried (1960) Chief Executive Officer & Director $810,270
Mr. Frank Louis Jaksch Jr. (1968) Co-Founder & Executive Chairman $592,420
Mr. Kevin M. Farr CPA (1958) Chief Financial Officer
$479,600
Monday, 9 December 2024
zacks.com
Tuesday, 3 December 2024
businesswire.com
Friday, 22 November 2024
zacks.com
Thursday, 21 November 2024
zacks.com
Thursday, 14 November 2024
businesswire.com
Friday, 8 November 2024
zacks.com
zacks.com
Thursday, 7 November 2024
businesswire.com
Tuesday, 5 November 2024
zacks.com
zacks.com
Friday, 1 November 2024
seekingalpha.com
Thursday, 31 October 2024
zacks.com
Tuesday, 29 October 2024
zacks.com
Monday, 28 October 2024
businesswire.com
Thursday, 24 October 2024
businesswire.com
Wednesday, 23 October 2024
businesswire.com
Friday, 18 October 2024
zacks.com
Tuesday, 15 October 2024
businesswire.com
Thursday, 26 September 2024
businesswire.com
zacks.com
Friday, 20 September 2024
businesswire.com
Tuesday, 10 September 2024
businesswire.com
Monday, 9 September 2024
businesswire.com
Friday, 23 August 2024
businesswire.com
Wednesday, 7 August 2024
zacks.com
Monday, 22 July 2024
businesswire.com
Tuesday, 16 July 2024
businesswire.com
Wednesday, 26 June 2024
seekingalpha.com
Monday, 24 June 2024
businesswire.com
Thursday, 13 June 2024
businesswire.com
  • What's the price of ChromaDex stock today?

    One share of ChromaDex stock can currently be purchased for approximately $7.89.

  • When is ChromaDex's next earnings date?

    Unfortunately, ChromaDex's (CDXC) next earnings date is currently unknown.

  • Does ChromaDex pay dividends?

    No, ChromaDex does not pay dividends.

  • How much money does ChromaDex make?

    ChromaDex has a market capitalization of 415.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 15.99% to 83.57M US dollars.

  • What is ChromaDex's stock symbol?

    ChromaDex Corporation is traded on the NASDAQ under the ticker symbol "CDXC".

  • What is ChromaDex's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of ChromaDex?

    Shares of ChromaDex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ChromaDex's key executives?

    ChromaDex's management team includes the following people:

    • Mr. Robert N. Fried Chief Executive Officer & Director(age: 65, pay: $810,270)
    • Mr. Frank Louis Jaksch Jr. Co-Founder & Executive Chairman(age: 57, pay: $592,420)
    • Mr. Kevin M. Farr CPA Chief Financial Officer(age: 67, pay: $479,600)
  • Is ChromaDex founder-led company?

    Yes, ChromaDex is a company led by its founder Mr. Frank Louis Jaksch Jr..

  • How many employees does ChromaDex have?

    As Jul 2024, ChromaDex employs 106 workers.

  • When ChromaDex went public?

    ChromaDex Corporation is publicly traded company for more then 17 years since IPO on 25 Jun 2008.

  • What is ChromaDex's official website?

    The official website for ChromaDex is chromadex.com.

  • Where are ChromaDex's headquarters?

    ChromaDex is headquartered at 10900 Wilshire Boulevard, Los Angeles, CA.

  • How can i contact ChromaDex?

    ChromaDex's mailing address is 10900 Wilshire Boulevard, Los Angeles, CA and company can be reached via phone at +31 3886706.

ChromaDex company profile:

ChromaDex Corporation

chromadex.com
Exchange:

NASDAQ

Full time employees:

106

Industry:

Biotechnology

Sector:

Healthcare

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

10900 Wilshire Boulevard
Los Angeles, CA 90024

CIK: 0001386570
ISIN: US1710774076
CUSIP: 171077407